FindTrial
Sign In

Wedge Resection versus Segmentectomy for =2 cm Ground-Glass-Opacity-Dominant Non-Small Cell Lung Cancer: A Real-World Study using Inverse Probability of Treatment Weighting

Wedge Resection versus Segmentectomy for =2 cm Ground-Glass-Opacity-Dominant Non-Small Cell Lung Cancer: A Real-World Study using Inverse Probability of Treatment Weighting

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079887
Enrollment
Unknown
Registered
2024-01-15
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Segmentectomy group:None
wedge resection:None

Sponsors

West China Hospital,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Tumor size less than or equal to 2 cm; GGO percentage greater than or equal to 50%; patients underwent lung segmentectomy or wedge resection;

Exclusion criteria

Exclusion criteria: patients with a previous cancer history; patients with a CTR > 0.5; and patients with missing follow-up data.

Design outcomes

Primary

MeasureTime frame
Overall Survival;Recurrence-free survival;—

Secondary

MeasureTime frame
Complication rate;operating time ;time of postoperative stay;—

Countries

China

Contacts

Public ContactLunxu Liu

West China Hospital,Sichuan University

lunxu_liu@aliyun.com+86 189 8060 1525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026